Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2012, Article ID 712425, 7 pages
http://dx.doi.org/10.1155/2012/712425
Review Article

Interpretation of Hormone Levels in Older Patients: Points for Consideration

Clinical Biochemistry Department, College of Medicine, Jagiellonian University, Wielicka Street 265, 30-663 Kracow, Poland

Received 2 December 2011; Revised 20 February 2012; Accepted 9 March 2012

Academic Editor: Huan Cai

Copyright © 2012 Krystyna Sztefko and Patrycja Szybowska. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Orentreich, J. L. Brind, J. H. Vogelman, R. Andres, and H. Baldwin, “Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 4, pp. 1002–1004, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Santoro and J. L. Chervenak, “The menopause transition,” Endocrinology and Metabolism Clinics of North America, vol. 33, no. 4, pp. 627–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Finkelstein, H. P. Roffwarg, R. M. Boyar, J. Kream, and L. Hellman, “Age-related change in the twenty-four-hour spontaneous secretion of growth hormone,” Journal of Clinical Endocrinology and Metabolism, vol. 35, no. 5, pp. 665–670, 1972. View at Google Scholar · View at Scopus
  4. D. Rudman, “Growth hormone, body composition, and aging,” Journal of the American Geriatrics Society, vol. 33, no. 11, pp. 800–807, 1985. View at Google Scholar · View at Scopus
  5. Z. Zadik, S. A. Chalew, and R. J. McCarter, “The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals,” Journal of Clinical Endocrinology and Metabolism, vol. 60, no. 3, pp. 513–516, 1985. View at Google Scholar · View at Scopus
  6. A. A. Mangoni and S. H. D. Jackson, “Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications,” British Journal of Clinical Pharmacology, vol. 57, no. 1, pp. 6–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Warner and G. J. Beckett, “Mechanisms behind the non-thyroidal illness syndrome: an update,” Journal of Endocrinology, vol. 205, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Sell, M. Schott, L. Tharandt, K. Cissewski, W. A. Scherbaum, and H. S. Willenberg, “Functional central hypothyroidism in the elderly,” Aging, vol. 20, no. 3, pp. 207–210, 2008. View at Google Scholar · View at Scopus
  9. S. Chatterjee, B. P. O'Malley, D. E. Price, A. M. Fielding, and R. Aitken, “Low but detectable serum thyroid-stimulating hormone concentrations in ambulant subjects not receiving thyroxine,” Annals of Clinical Biochemistry, vol. 40, no. 6, pp. 639–642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Georges, A. Charrié, S. Raynaud, C. Lombard, and J. B. Corcuff, “Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 5, pp. 873–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Martín, P. Marquet, J. M. Ferrer et al., “Rheumatoid factor interference in a tacrolimus immunoassay,” Therapeutic Drug Monitoring, vol. 31, no. 6, pp. 743–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Berth, E. Bosmans, J. Everaert et al., “Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9),” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 9, pp. 1137–1139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. N. Makaryus, M. N. Makaryus, and B. Hassid, “Falsely elevated cardiac troponin I levels,” Clinical Cardiology, vol. 30, no. 2, pp. 92–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sapin, “Interferences in immunoassays: mechanisms and outcomes in endocrinology,” Annales d'Endocrinologie, vol. 69, no. 5, pp. 415–425, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Snyder, M. W. Rogers, M. S. King, J. C. Phillips, J. F. Chapman, and C. A. Hammett-Stabler, “The impact of hemolysis on Ortho-Clinical Diagnostic's ECi and Roche's elecsys immunoassay systems,” Clinica Chimica Acta, vol. 348, no. 1-2, pp. 181–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. Jones and J. W. Honour, “Unusual results from immunoassays and the role of the clinical endocrinologist,” Clinical Endocrinology, vol. 64, no. 3, pp. 234–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Florkowski, J. Wallace, T. Walmsley, and P. George, “The effect of hemolysis on current troponin assays—a confounding preanalytical variable?” Clinical Chemistry, vol. 56, no. 7, pp. 1195–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Oddoze, E. Lombard, and H. Portugal, “Stability study of 81 analytes in human whole blood, in serum and in plasma,” Clinical Biochemistry, vol. 45, no. 6, pp. 464–469, 2012. View at Google Scholar
  19. J. H. Livesey and B. Dolamore, “Stability of plasma adrenocorticotrophic hormone (ACTH): influence of hemolysis, rapid chilling, time, and the addition of a maleimide,” Clinical Biochemistry, vol. 43, no. 18, pp. 1478–1480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Blatnik and C. I. Soderstrom, “A practical guide for the stabilization of acylghrelin in human blood collections,” Clinical Endocrinology, vol. 74, no. 3, pp. 325–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Di Marino, E. Griffo, S. Maione, and M. Mirabella, “Active glucagon-like peptide-1 (GLP-1): storage of human plasma and stability over time,” Clinica Chimica Acta, vol. 412, no. 17-18, pp. 1693–1694, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Faggiano, M. Del Prete, F. Marciello, V. Marotta, V. Ramundo, and A. Colao, “Thyroid diseases in elderly,” Minerva Endocrinologica, vol. 36, no. 3, pp. 211–231, 2011. View at Google Scholar · View at Scopus
  23. M. Bidlingmaier and P. U. Freda, “Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences,” Growth Hormone and IGF Research, vol. 20, no. 1, pp. 19–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Wheeler, “Assays for LH, FSH, and prolactin,” Methods in Molecular Biology, vol. 324, pp. 109–124, 2006. View at Google Scholar · View at Scopus
  25. A. Varro and J. E. S. Ardill, “Gastrin: an analytical review,” Annals of Clinical Biochemistry, vol. 40, no. 5, pp. 472–480, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Neal and W. Han, “Insulin immunoassays in the detection of insulin analogues in factitious hypoglycemia,” Endocrine Practice, vol. 14, no. 8, pp. 1006–1010, 2008. View at Google Scholar · View at Scopus
  27. R. Sapin, “Insulin assays: previously known and new analytical features,” Clinical Laboratory, vol. 49, no. 3-4, pp. 113–121, 2003. View at Google Scholar · View at Scopus
  28. K. Sztefko, Immunodiagnostics and Patient Safety, Walter de Gruyter GmbH, 2011.
  29. M. T. Ackermans, L. P. Klieverik, E. Endert, H. P. Sauerwein, A. Kalsbeek, and E. Fliers, “Plasma insulin concentrations during a hyperinsulinaemic clamp: what do we measure?” Annals of Clinical Biochemistry, vol. 45, no. 4, pp. 429–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. B. B. Kahn, B. D. Weintraub, G. Csako, and M. H. Zweig, “Factitious elevation of thyrotropin in a new ultrasensitive assay: implications for the use of monoclonal antibodies in “sandwich” immunoassay,” Journal of Clinical Endocrinology and Metabolism, vol. 66, no. 3, pp. 526–533, 1988. View at Google Scholar · View at Scopus
  31. C. Jansson, C. Boguszewski, S. Rosberg, L. Carlsson, and K. Albertsson-Wikland, “Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein,” Clinical Chemistry, vol. 43, no. 6, pp. 950–956, 1997. View at Google Scholar · View at Scopus
  32. W. E. Owen, M. L. Gantzer, J. M. Lyons, A. L. Rockwood, and W. L. Roberts, “Functional sensitivity of seven automated thyroid stimulating hormone immunoassays,” Clinica Chimica Acta, vol. 412, no. 23-24, pp. 2336–2339, 2011. View at Google Scholar
  33. H. J. Sung, J. H. Kim, R. Park, K. R. Lee, and O. H. Kwon, “Evaluation of Denka-Seiken turbidimetric high-sensitivity C-reactive protein assay,” Clinical Chemistry and Laboratory Medicine, vol. 40, no. 8, pp. 840–845, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Bay, A. M. Andersson, and N. E. Skakkebaek, “Estradiol levels in prepubertal boys and girls—analytical challenges,” International Journal of Andrology, vol. 27, no. 5, pp. 266–273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. F. S. Apple, P. O. Collinson, and IFCC Task Force on Clinical Applications of Cardiac Biomarkers, “Analytical characteristics of high-sensitivity cardiac troponin assays,” Clinical Chemistry, vol. 58, no. 1, pp. 54–61, 2012. View at Google Scholar
  36. A. H. B. Wu, “Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series,” Clinica Chimica Acta, vol. 401, no. 1-2, pp. 170–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Amarasiri Fernando and G. S. Wilson, “Studies of the “hook” effect in the one-step sandwich immunoassay,” Journal of Immunological Methods, vol. 151, no. 1-2, pp. 47–66, 1992. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Jassam, C. M. Jones, T. Briscoe, and J. H. Horner, “The hook effect: a need for constant vigilance,” Annals of Clinical Biochemistry, vol. 43, no. 4, pp. 314–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. C. Forest, J. Massé, and A. Lane, “Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer,” Clinical Biochemistry, vol. 31, no. 2, pp. 81–88, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Agarwal, A. Das, and A. Singh, “High-dose hook effect in prolactin macroadenomas: a diagnostic concern,” Journal of Human Reproductive Sciences, vol. 3, no. 3, pp. 160–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. T. W. Frieze, D. P. Mong, and M. K. Koops, ““Hook effect” in prolactinomas: case report and review of literature,” Endocrine Practice, vol. 8, no. 4, pp. 296–303, 2002. View at Google Scholar · View at Scopus
  42. N. G. Morgenthaler, J. Froehlich, J. Rendl et al., “Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin,” Clinical Chemistry, vol. 48, no. 7, pp. 1077–1083, 2002. View at Google Scholar · View at Scopus
  43. S. Akamatsu, H. Tsukazaki, K. Inoue, and Y. Nishio, “Advanced prostate cancer with extremely low prostate-specific antigen value at diagnosis: an example of high dose hook effect,” International Journal of Urology, vol. 13, no. 7, pp. 1025–1027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Basuyau, M. Leroy, and P. Brunelle, “Determination of tumor markers in serum. Pitfalls and good practice,” Clinical Chemistry and Laboratory Medicine, vol. 39, no. 12, pp. 1227–1233, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Corpas, S. M. Harman, and M. R. Blackman, “Human growth hormone and human aging,” Endocrine Reviews, vol. 14, no. 1, pp. 20–39, 1993. View at Publisher · View at Google Scholar · View at Scopus
  46. L. C. Rall, R. Roubenoff, and T. B. Harris, “Albumin as a marker of nutritional and health status,” in Nutritional Assessment of Elderly Populations, I. H. Rosenberg, Ed., vol. 13, pp. 40–49, Raven Press, New York, NY, USA, 1995. View at Google Scholar
  47. N. W. Tietz, D. F. Shuey, and D. R. Wekstein, “Laboratory values in fit aging individuals - Sexagenarians through centenarians,” Clinical Chemistry, vol. 38, no. 6, pp. 1167–1185, 1992. View at Google Scholar · View at Scopus
  48. M. L. Omran and J. E. Morley, “Assessment of protein energy malnutrition in older persons, part II: laboratory evaluation,” Nutrition, vol. 16, no. 2, pp. 131–140, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Gavazzi and K. H. Krause, “Ageing and infection,” The Lancet Infectious Diseases, vol. 2, no. 11, pp. 659–666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. V. T. G. Chuangl and M. Otagiri, “Stereoselective binding of human serum albumin,” Chirality, vol. 18, no. 3, pp. 159–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. J. R. Simard, P. A. Zunszain, J. A. Hamilton, and S. Curry, “Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis,” Journal of Molecular Biology, vol. 361, no. 2, pp. 336–351, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. G. C. Schussler, “The thyroxine-binding proteins,” Thyroid, vol. 10, no. 2, pp. 141–149, 2000. View at Google Scholar · View at Scopus
  53. F. A. De Wolf and G. M. Brett, “Ligand-binding proteins: their potential for application in systems for controlled delivery and uptake of ligands,” Pharmacological Reviews, vol. 52, no. 2, pp. 207–236, 2000. View at Google Scholar · View at Scopus
  54. R. Tahboub and B. M. Arafah, “Sex steroids and the thyroid,” Best Practice and Research, vol. 23, no. 6, pp. 769–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. P. Stevenson, G. P. R. Archbold, P. Johnston, I. S. Young, and B. Sheridan, “Misleading serum free thyroxine results during low molecular weight heparin treatment,” Clinical Chemistry, vol. 44, no. 5, pp. 1002–1007, 1998. View at Google Scholar · View at Scopus
  56. A. Dasgupta, “Clinical utility of free drug monitoring,” Clinical Chemistry and Laboratory Medicine, vol. 40, no. 10, pp. 986–993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. L. D. Kerr, “Inflammatory arthropathy: a review of rheumatoid arthritis in older patients,” Geriatrics, vol. 59, no. 10, pp. 32–35, 2004. View at Google Scholar · View at Scopus
  58. J. T. Diep and P. D. Gorevic, “Geriatric autoimmune diseases: systemic lupus erythematosus, Sjogren's syndrome, and myositis,” Geriatrics, vol. 60, no. 5, pp. 32–38, 2005. View at Google Scholar · View at Scopus
  59. D. J. Miller-Blair and D. L. Robbins, “Rheumatoid arthritis: new science, new treatment,” Geriatrics, vol. 48, no. 6, pp. 28–38, 1993. View at Google Scholar · View at Scopus
  60. C. P. Chong and P. R. Street, “Pneumonia in the elderly: a review of the epidemiology, pathogenesis, microbiology, and clinical features,” Southern Medical Journal, vol. 101, no. 11, pp. 1141–1145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Tomer and Y. Shoenfeld, “Ageing and autoantibodies,” Autoimmunity, vol. 1, no. 2, pp. 141–149, 1988. View at Google Scholar · View at Scopus
  62. M. N. Manoussakis, A. G. Tzioufas, M. P. Silis, P. J. Pange, J. Goudevenos, and H. M. Moutsopoulos, “High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population,” Clinical and Experimental Immunology, vol. 69, no. 3, pp. 557–565, 1987. View at Google Scholar
  63. S. Mariotti, L. Chiovato, C. Franceschi, and A. Pinchera, “Thyroid autoimmunity and aging,” Experimental Gerontology, vol. 33, no. 6, pp. 535–541, 1998. View at Google Scholar · View at Scopus
  64. A. Iervasi, G. Iervasi, A. Carpi, and G. C. Zucchelli, “Serum thyroglobulin measurement: clinical background andmain methodological aspects with clinical impact,” Biomedicine and Pharmacotherapy, vol. 60, no. 8, pp. 414–424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. C. A. Spencer and J. S. LoPresti, “Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 4, pp. 223–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. A. B. Schneider and R. Pervos, “Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies,” Journal of Clinical Endocrinology and Metabolism, vol. 47, no. 1, pp. 126–137, 1978. View at Google Scholar · View at Scopus
  67. C. A. Spencer, M. Takeuchi, and M. Kazarosyan, “Current status and performance goals for serum thyroglobulin assays,” Clinical Chemistry, vol. 42, no. 1, pp. 164–173, 1996. View at Google Scholar · View at Scopus
  68. M. Adamczyk, R. J. Brashear, and P. G. Mattingly, “Prevalence of autoantibodies to cardiac troponin T in healthy blood donors,” Clinical Chemistry, vol. 55, no. 8, pp. 1592–1593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Eriksson, H. Halenius, K. Pulkki, J. Hellman, and K. Pettersson, “Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies,” Clinical Chemistry, vol. 51, no. 5, pp. 839–847, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Plebani, M. Mion, S. Altinier, M. A. Girotto, G. Baldo, and M. Zaninotto, “False-positive troponin I attributed to a macrocomplex,” Clinical Chemistry, vol. 48, no. 4, pp. 677–679, 2002. View at Google Scholar · View at Scopus
  71. J. F. Emerson, G. Ngo, and S. S. Emerson, “Screening for interference in immunoassays,” Clinical Chemistry, vol. 49, no. 7, pp. 1163–1169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. R. W. Schroff, K. A. Foon, and S. M. Beatty, “Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy,” Cancer Research, vol. 45, no. 2, pp. 879–885, 1985. View at Google Scholar · View at Scopus
  73. K. R. Moseley, R. C. Knapp, and H. J. Haisma, “An assay for the detection of human anti-murine immunoglobulins in the presence of CA125 antigen,” Journal of Immunological Methods, vol. 106, no. 1, pp. 1–6, 1988. View at Publisher · View at Google Scholar · View at Scopus
  74. A. W. Butch, “Falsely increased values for rabbit immunoglobulin-based nephelometric immunoassays attributable to human anti-rabbit antibodies,” Clinical Chemistry, vol. 46, no. 8 I, pp. 1207–1208, 2000. View at Google Scholar · View at Scopus
  75. J. F. Emerson, G. Ngo, and S. S. Emerson, “Screening for interference in immunoassays,” Clinical Chemistry, vol. 49, no. 7, pp. 1163–1169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Bolstad, D. J. Warren, J. Bjerner et al., “Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 12, pp. 2001–2006, 2011. View at Publisher · View at Google Scholar
  77. K. P. Kohse and H. Wisser, “Antibodies as a source of analytical errors,” Journal of Clinical Chemistry and Clinical Biochemistry, vol. 28, no. 12, pp. 881–892, 1990. View at Google Scholar · View at Scopus
  78. A. A. A. Ismail, P. L. Walker, M. L. Cawood, and J. H. Barth, “Interference in immunoassay is an underestimated problem,” Annals of Clinical Biochemistry, vol. 39, no. 4, pp. 366–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. C. M. Sturgeon and A. Viljoen, “Analytical error and interference in immunoassay: minimizing risk,” Annals of Clinical Biochemistry, vol. 48, no. 5, pp. 418–432, 2011. View at Google Scholar
  80. S. Koshida, K. Asanuma, K. Kuribayashi et al., “Prevalence of human anti-mouse antibodies (HAMAs) in routine examinations,” Clinica Chimica Acta, vol. 411, no. 5-6, pp. 391–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Cavalier, A. Carlisi, J. P. Chapelle et al., “Human anti-mouse antibodies interferences in elecsys PTH assay after OKT3 treatment,” Transplantation, vol. 87, no. 3, pp. 451–452, 2009. View at Publisher · View at Google Scholar · View at Scopus